| Literature DB >> 32860401 |
Tyler Vaivada1, Nadia Akseer1,2, Selai Akseer1, Ahalya Somaskandan1, Marianne Stefopulos1, Zulfiqar A Bhutta1,2,3.
Abstract
BACKGROUND: Progress has been made worldwide in reducing chronic undernutrition and rates of linear growth stunting in children under 5 y of age, although rates still remain high in many regions. Policies, programs, and interventions supporting maternal and child health and nutrition have the potential to improve child growth and development.Entities:
Keywords: child; height; infant; length; linear growth; nutrition; stunting
Mesh:
Year: 2020 PMID: 32860401 PMCID: PMC7487433 DOI: 10.1093/ajcn/nqaa159
Source DB: PubMed Journal: Am J Clin Nutr ISSN: 0002-9165 Impact factor: 7.045
FIGURE 1Global and regional comparison of the total number of children aged 0–59 mo experiencing linear growth stunting in 1990 and 2019. Source of data: UNICEF, World Bank Group joint malnutrition estimates, 2020 edition (6). Data not available for Europe and Central Asia.
FIGURE 4Stunting prevalence, top-performing countries. Source of data: UNICEF, WHO, World Bank Group joint malnutrition estimates, 2020 edition (6).
FIGURE 2Stunting prevalence for children under 5 y based on the most recently available country-level estimates. Map based on longitude (generated) and latitude (generated). Color shows sum of stunting prevalence. Details are shown for country. Source of data: UNICEF, WHO, World Bank Group joint malnutrition estimates, 2020 edition (6). Data not available for Europe and Central Asia.
FIGURE 3Global and regional trends in stunting prevalence, 1990–2019. Source of data: UNICEF, WHO, World Bank Group joint malnutrition estimates, 2020 edition (6). Data not available for Europe and Central Asia.
FIGURE 5Conceptual framework of child stunting determinants. Determinants include those identified during the review process, and are based on those originally described in the UNICEF Undernutrition Conceptual Framework (8) and 2013 Lancet Maternal and Child Nutrition Series framework (1).
Summary of changes in stunting prevalence and HAZ statistically explained by changes in stunting determinant indicators within regression-decomposition analyses.
|
|
Buisman 2019: Maternal Risk (birth order, birth interval > 24 months, mothers taller than 150 cm, mother's age at birth)
Ervin 2019: ln(income), delayed vaccines, child breastfed at birth, ln(birth interval)
Ikeda 2013: Outcome is stunting prevalence, all other studies included outcome is HAZ
*0–23 months
**0–47 months
***0–10 years
†The total variance is the variance calculated by the study authors. Some models have adjusted for other covariates that have not been included in this table.